448 related articles for article (PubMed ID: 28988129)
1. Assessment of synergistic antibacterial activity of combined biosurfactants revealed by bacterial cell envelop damage.
Sana S; Datta S; Biswas D; Sengupta D
Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):579-585. PubMed ID: 28988129
[TBL] [Abstract][Full Text] [Related]
2. Rhamnolipid (RL) from Pseudomonas aeruginosa OBP1: a novel chemotaxis and antibacterial agent.
Bharali P; Saikia JP; Ray A; Konwar BK
Colloids Surf B Biointerfaces; 2013 Mar; 103():502-9. PubMed ID: 23261573
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity and mode of action of ferulic and gallic acids against pathogenic bacteria.
Borges A; Ferreira C; Saavedra MJ; Simões M
Microb Drug Resist; 2013 Aug; 19(4):256-65. PubMed ID: 23480526
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of Syzygium aromaticum seed: Studies on oxidative stress biomarkers and membrane permeability.
Ajiboye TO; Mohammed AO; Bello SA; Yusuf II; Ibitoye OB; Muritala HF; Onajobi IB
Microb Pathog; 2016 Jun; 95():208-215. PubMed ID: 27038843
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA).
Aruldass CA; Masalamany SRL; Venil CK; Ahmad WA
Environ Sci Pollut Res Int; 2018 Feb; 25(6):5164-5180. PubMed ID: 28361404
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial mode of fibrauretine and synergistic effect with kanamycin against multi-drug resistant Escherichia coli.
Wang YM; Kong LC; Liu L; Odah KA; Liu SM; Jiang XY; Ma HX
Biotechnol Lett; 2019 Sep; 41(8-9):1023-1031. PubMed ID: 31203568
[TBL] [Abstract][Full Text] [Related]
7. Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk.
Picoli T; Peter CM; Zani JL; Waller SB; Lopes MG; Boesche KN; Vargas GDÁ; Hübner SO; Fischer G
Microb Pathog; 2017 Nov; 112():57-62. PubMed ID: 28943153
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization and surface activities of biogenic rhamnolipid surfactants from Pseudomonas aeruginosa isolate MN1 and synergistic effects against methicillin-resistant Staphylococcus aureus.
Samadi N; Abadian N; Ahmadkhaniha R; Amini F; Dalili D; Rastkari N; Safaripour E; Mohseni FA
Folia Microbiol (Praha); 2012 Nov; 57(6):501-8. PubMed ID: 22644668
[TBL] [Abstract][Full Text] [Related]
9. Mannosylerythritol lipids: dual inhibitory modes against Staphylococcus aureus through membrane-mediated apoptosis and biofilm disruption.
Shu Q; Wei T; Lu H; Niu Y; Chen Q
Appl Microbiol Biotechnol; 2020 Jun; 104(11):5053-5064. PubMed ID: 32248439
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antibacterial activity, synergistic effect, cytotoxicity, docking and molecular dynamics of benzimidazole analogues.
Srivastava R; Gupta SK; Naaz F; Singh A; Singh VK; Verma R; Singh N; Singh RK
Comput Biol Chem; 2018 Oct; 76():1-16. PubMed ID: 29857255
[TBL] [Abstract][Full Text] [Related]
11. PA-1, a novel synthesized pyrrolizidine alkaloid, inhibits the growth of Escherichia coli and Staphylococcus aureus by damaging the cell membrane.
Li N; Tan SN; Cui J; Guo N; Wang W; Zu YG; Jin S; Xu XX; Liu Q; Fu YJ
J Antibiot (Tokyo); 2014 Oct; 67(10):689-96. PubMed ID: 24894184
[TBL] [Abstract][Full Text] [Related]
12. Cooperative Behavior of Fluoroquinolone Combinations against Escherichia coli and Staphylococcus aureus.
Vitorino GP; Becerra MC; Barrera GD; Caira MR; Mazzieri MR
Biol Pharm Bull; 2017; 40(6):758-764. PubMed ID: 28566620
[TBL] [Abstract][Full Text] [Related]
13. Interference in adhesion of bacteria and yeasts isolated from explanted voice prostheses to silicone rubber by rhamnolipid biosurfactants.
Rodrigues LR; Banat IM; van der Mei HC; Teixeira JA; Oliveira R
J Appl Microbiol; 2006 Mar; 100(3):470-80. PubMed ID: 16478486
[TBL] [Abstract][Full Text] [Related]
14. Colloidal and antibacterial properties of novel triple-headed, double-tailed amphiphiles: exploring structure-activity relationships and synergistic mixtures.
Marafino JN; Gallagher TM; Barragan J; Volkers BL; LaDow JE; Bonifer K; Fitzgerald G; Floyd JL; McKenna K; Minahan NT; Walsh B; Seifert K; Caran KL
Bioorg Med Chem; 2015 Jul; 23(13):3566-73. PubMed ID: 25936261
[TBL] [Abstract][Full Text] [Related]
15. Violacein@Biogenic Ag system: synergistic antibacterial activity against Staphylococcus aureus.
Nakazato G; Gonçalves MC; da Silva das Neves M; Kobayashi RKT; Brocchi M; Durán N
Biotechnol Lett; 2019 Dec; 41(12):1433-1437. PubMed ID: 31650420
[TBL] [Abstract][Full Text] [Related]
16. Effect of biosurfactants on Pseudomonas aeruginosa and Staphylococcus aureus biofilms in a BioFlux channel.
Diaz De Rienzo MA; Stevenson PS; Marchant R; Banat IM
Appl Microbiol Biotechnol; 2016 Jul; 100(13):5773-9. PubMed ID: 26825819
[TBL] [Abstract][Full Text] [Related]
17. The antibacterial activity of rhamnolipid biosurfactant is pH dependent.
de Freitas Ferreira J; Vieira EA; Nitschke M
Food Res Int; 2019 Feb; 116():737-744. PubMed ID: 30717003
[TBL] [Abstract][Full Text] [Related]
18. Effects of rhamnolipid-biosurfactant on cell surface of Pseudomonas aeruginosa.
Sotirova A; Spasova D; Vasileva-Tonkova E; Galabova D
Microbiol Res; 2009; 164(3):297-303. PubMed ID: 17416508
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of a rhamnolipid-type biosurfactant produced by Pseudomonas aeruginosa MR01: enhancement of di-rhamnolipid proportion using gamma irradiation.
Lotfabad TB; Abassi H; Ahmadkhaniha R; Roostaazad R; Masoomi F; Zahiri HS; Ahmadian G; Vali H; Noghabi KA
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):397-405. PubMed ID: 20732795
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity, structure and CMC relationships of alkanediyl alpha,omega-bis(dimethylammonium bromide) surfactants.
Laatiris A; El Achouri M; Infante MR; Bensouda Y
Microbiol Res; 2008; 163(6):645-50. PubMed ID: 17207986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
